AI and the future of biomarker analysis in early R&D
AI is transforming biomarker analysis in early drug discovery, revealing…
AI is transforming biomarker analysis in early drug discovery, revealing hidden biological patterns that improve target discovery, patient selection and trial design for more precise and predictive R&D.




